Merck Ranked Top on List of America’s Most Responsible Companies 2025

Merck, also known as MSD outside of the United States and Canada, has once again secured the top spot on Newsweek’s annual list of America’s Most Responsible Companies. This marks the second consecutive year that Merck has received this prestigious recognition.

Robert M. Davis, the chairman and chief executive officer of Merck, emphasized the company’s commitment to upholding the highest standards of ethics and integrity. He stated that responsibility is a fundamental value embedded in Merck’s operations as they strive to save and enhance lives through their work.

To compile this year’s list, Newsweek collaborated with Statista, a global research and data firm, to evaluate 2,000 of the largest public companies in the United States based on revenue. The assessment considered 30 key performance indicators and included feedback from 26,000 U.S. residents.

In addition to earning the top ranking from Newsweek, Merck was also recognized as the leading company in its industry by CNBC and JUST Capital’s list of America’s Most JUST Companies, as well as Barron’s list of the 100 Most Sustainable U.S. Companies.

For those interested in learning more about Merck’s sustainability initiatives, they can visit the company’s website at merck.com/company-overview/sustainability.

Merck, operating under the name MSD internationally, is dedicated to leveraging cutting-edge science to improve lives worldwide. With over 130 years of experience, Merck has been at the forefront of developing essential medicines and vaccines that bring hope to humanity. The company aims to be a premier research-intensive biopharmaceutical organization, focusing on delivering innovative health solutions for disease prevention and treatment in both humans and animals. Merck is committed to maintaining a diverse and inclusive global workforce while prioritizing responsible practices to create a safe, sustainable, and healthy future for all.

As a precaution, it’s important to note that the forward-looking statements included in this news release by Merck & Co., Inc. are subject to risks and uncertainties. These statements are based on the company’s current beliefs and expectations, and actual results could vary if assumptions prove incorrect or if risks and uncertainties materialize. It’s advisable to review the company’s Annual Report on Form 10-K for a comprehensive understanding of the factors impacting future outcomes.

For media inquiries, individuals can reach out to Robert Josephson at (203) 914-2372 or robert.josephson@merck.com. For investor concerns, Peter Dannenbaum can be contacted at (732) 594-1579 or peter.dannenbaum@merck.com. Steven Graziano is available for investor relations at (732) 594-1583 or steven.graziano@merck.com.